Literature DB >> 1595476

Sequential cranial MR findings of asymptomatic and neurologically symptomatic HIV+ subjects.

M J Post1, B E Levin, J R Berger, R Duncan, R M Quencer, G Calabro.   

Abstract

PURPOSE: To compare results of a prospective MR and clinical reevaluation of HIV+ asymptomatic and neurologically symptomatic subjects who had had initially abnormal cranial studies to determine what cranial MR changes occur and how these changes correlate with serial neurologic and neuropsychologic findings. PATIENTS AND METHODS: Thirty-one asymptomatic (n = 20) and neurologically symptomatic (n = 11) subjects seropositive for the human immunodeficiency virus (HIV+) were prospectively reevaluated by cranial magnetic resonance (MR) one to two years following an initially abnormal MR of the brain.
RESULTS: All 31 HIV+ subjects with initial abnormal MR had abnormal follow-up scans (showing atrophy and/or white matter lesions). Twenty-seven showed no progression of MR abnormalities (among whom were 18 with minimally abnormal scans who remained asymptomatic with improved or static neuropsychologic performance). Of the four subjects with scan changes (all with clinically suspected HIV encephalopathy), one showed MR, clinical, and neuropsychologic test improvement; the remaining three showed MR (n = 3), neurologic (n = 3), neuropsychologic (n = 1) worsening and autopsy (n = 1) confirmed the presence of HIV-1 containing multinucleated giant cells in the brain.
CONCLUSIONS: This study suggests that: 1) Progression of intracranial MR abnormalities due to HIV-1 is seen only in a minority of HIV+ subjects over a 1- to 2-year time period, only in those neurologically symptomatic, and correlates with clinical deterioration. 2) Minor cerebral MR abnormalities seen in HIV+ subjects who remain neurologically asymptomatic do not change over a 1- to 2-year period. 3) Although HIV is known to infect the brain early, it may, nevertheless, not routinely do significant anatomical damage early on in the disease, as based on MR criteria.

Entities:  

Mesh:

Year:  1992        PMID: 1595476      PMCID: PMC8331759     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  7 in total

1.  Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment.

Authors:  Clayton A Wiley; Brian J Lopresti; James T Becker; Fernando Boada; Oscar L Lopez; John Mellors; Carolyn C Meltzer; Stephen R Wisniewski; Chester A Mathis
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

2.  Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course.

Authors:  M M Thurnher; E G Schindler; S A Thurnher; H Pernerstorfer-Schön; C Kleibl-Popov; A Rieger
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

3.  Neurologic disease in captive lions (Panthera leo) with low-titer lion lentivirus infection.

Authors:  Greg Brennan; Michael D Podell; Raymund Wack; Susan Kraft; Jennifer L Troyer; Helle Bielefeldt-Ohmann; Sue VandeWoude
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

4.  Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study.

Authors:  M J Harrison; S P Newman; M A Hall-Craggs; C J Fowler; R Miller; B E Kendall; M Paley; I Wilkinson; B Sweeney; S Lunn; S Carter; I Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

5.  Focal brain lesions in patients with AIDS: aetiologies and corresponding radiological patterns in a prospective study.

Authors:  H Steinmetz; G Arendt; H Hefter; E Neuen-Jacob; K Dörries; A Aulich; T Kahn
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

6.  PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS.

Authors:  Sriram Venneti; Brian J Lopresti; Guoji Wang; Stephanie J Bissel; Chester A Mathis; Carolyn C Meltzer; Fernando Boada; Saverio Capuano; Geraldine J Kress; Denise K Davis; James Ruszkiewicz; Ian J Reynolds; Michael Murphey-Corb; Anita M Trichel; Stephen R Wisniewski; Clayton A Wiley
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 7.  Human immunodeficiency virus type 1 infection of the brain.

Authors:  W J Atwood; J R Berger; R Kaderman; C S Tornatore; E O Major
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.